Cerebral beta-endorphin levels in a woman with Prader-Labhart-Willi syndrome.
By means of a specific two-site immunoradiometric assay, we explored the beta-endorphin levels in various brain regions of a patient affected by Prader-Labhart-Willi Syndrome. The rank of the beta-endorphin levels of five cerebral zones (hypothalamus, substantia grisea centralis, pons dorsalis, medulla oblongata dorsalis medialis, thalamus medialis) of the patient was homologous to that of subjects without the syndrome, except for the medulla oblongata dorsalis medialis. In patient with the Prader-Labhart-Willi Syndrome this region had a higher ranking level than in subjects without it. However, a functional meaning cannot be attributed to such difference because the patient of this study did not exhibit neurological disturbances relating to elevated beta-endorphin levels in the medullary region investigated.
Pasi
A
A
Institute of Forensic Medicine, University of Zurich, Switzerland.
Mehraein
P
P
Gramsch
C
C
Jehle
A
A
Briner
J
J
Häni
M
M
Külling
P
P
Hauri
R
R
Messiha
F S
FS
D000328:Adult; D001921:Brain / Q000473:pathology*; D001931:Brain Mapping; D003645:Death, Sudden / Q000473:pathology*; D005260:Female; D006801:Humans; D015592:Immunoradiometric Assay; D011218:Prader-Willi Syndrome / Q000473:pathology*; D001615:beta-Endorphin / Q000378:metabolism*
D001615:beta-Endorphin